A detailed history of Good Life Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Good Life Advisors, LLC holds 50,737 shares of ABBV stock, worth $9.05 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
50,737
Previous 47,947 5.82%
Holding current value
$9.05 Million
Previous $8.22 Million 21.84%
% of portfolio
0.64%
Previous 0.69%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$163.84 - $199.33 $457,113 - $556,130
2,790 Added 5.82%
50,737 $10 Million
Q2 2024

Jul 17, 2024

BUY
$154.79 - $180.76 $340,692 - $397,852
2,201 Added 4.81%
47,947 $8.22 Million
Q1 2024

May 02, 2024

BUY
$159.82 - $182.1 $79,110 - $90,139
495 Added 1.09%
45,746 $8.33 Million
Q4 2023

Jan 18, 2024

BUY
$137.6 - $154.97 $306,572 - $345,273
2,228 Added 5.18%
45,251 $7.01 Million
Q3 2023

Oct 19, 2023

BUY
$133.59 - $154.65 $2.7 Million - $3.12 Million
20,186 Added 88.39%
43,023 $6.41 Million
Q2 2023

Jul 10, 2023

BUY
$132.51 - $164.9 $360,559 - $448,692
2,721 Added 13.53%
22,837 $3.08 Million
Q1 2023

May 05, 2023

BUY
$144.61 - $166.54 $228,917 - $263,632
1,583 Added 8.54%
20,116 $3.21 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $1.01 Million - $1.21 Million
7,322 Added 65.31%
18,533 $3 Million
Q3 2022

Oct 13, 2022

BUY
$134.21 - $153.93 $25,499 - $29,246
190 Added 1.72%
11,211 $1.51 Million
Q2 2022

Jul 19, 2022

SELL
$137.62 - $174.96 $52,433 - $66,659
-381 Reduced 3.34%
11,021 $1.69 Million
Q1 2022

Apr 26, 2022

SELL
$131.98 - $163.75 $112,182 - $139,187
-850 Reduced 6.94%
11,402 $1.85 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $31,047 - $39,283
289 Added 2.42%
12,252 $1.66 Million
Q3 2021

Oct 29, 2021

BUY
$106.4 - $120.78 $83,311 - $94,570
783 Added 7.0%
11,963 $1.29 Million
Q2 2021

Jul 29, 2021

SELL
$105.21 - $117.21 $101,317 - $112,873
-963 Reduced 7.93%
11,180 $1.26 Million
Q1 2021

Apr 27, 2021

BUY
$102.3 - $112.62 $80,714 - $88,857
789 Added 6.95%
12,143 $1.31 Million
Q4 2020

Feb 04, 2021

SELL
$80.49 - $108.67 $12,797 - $17,278
-159 Reduced 1.38%
11,354 $1.21 Million
Q3 2020

Oct 19, 2020

SELL
$85.91 - $100.83 $33,247 - $39,021
-387 Reduced 3.25%
11,513 $1.01 Million
Q2 2020

Jul 20, 2020

BUY
$73.37 - $98.18 $31,989 - $42,806
436 Added 3.8%
11,900 $1.17 Million
Q1 2020

May 01, 2020

SELL
$64.5 - $97.79 $7,482 - $11,343
-116 Reduced 1.0%
11,464 $878,000
Q4 2019

Jan 17, 2020

BUY
$72.13 - $90.25 $24,452 - $30,594
339 Added 3.02%
11,580 $1.03 Million
Q3 2019

Nov 08, 2019

BUY
$62.98 - $75.72 $26,073 - $31,348
414 Added 3.82%
11,241 $859,000
Q2 2019

Aug 06, 2019

BUY
$65.7 - $83.98 $98,484 - $125,886
1,499 Added 16.07%
10,827 $792,000
Q1 2019

May 09, 2019

SELL
$77.14 - $90.79 $1,234 - $1,452
-16 Reduced 0.17%
9,328 $752,000
Q4 2018

Feb 01, 2019

SELL
$77.85 - $96.01 $101,905 - $125,677
-1,309 Reduced 12.29%
9,344 $861,000
Q3 2018

Oct 26, 2018

BUY
$88.91 - $98.84 $52,723 - $58,612
593 Added 5.89%
10,653 $1.01 Million
Q2 2018

Aug 07, 2018

BUY
$89.78 - $106.23 $48,211 - $57,045
537 Added 5.64%
10,060 $933,000
Q1 2018

May 01, 2018

BUY
$92.01 - $123.21 $575,062 - $770,062
6,250 Added 190.96%
9,523 $871,000
Q4 2017

Feb 12, 2018

SELL
$89.56 - $98.21 $18,001 - $19,740
-201 Reduced 5.79%
3,273 $328,000
Q3 2017

Nov 01, 2017

BUY
$69.85 - $89.22 $5,029 - $6,423
72 Added 2.12%
3,474 $320,000
Q2 2017

Aug 08, 2017

BUY
N/A
3,402
3,402 $247,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Good Life Advisors, LLC Portfolio

Follow Good Life Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Good Life Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Good Life Advisors, LLC with notifications on news.